"I believe that my identity as a woman in this discipline enhances the application of a well-rounded and multifaceted approach to scientific exploration.”
"My leadership journey has reinforced the power of visibility: 'You can't be what you can't see.' I hope my role inspires others to pursue leadership, even if they once doubted their place in this field.”
Today is International Women's Day, and SNMMI celebrates all of the trailblazing women in the nuclear medicine field whose expertise, passion, and dedication contribute to the highest standards of patient care.
Join us for episode 6 of the JNM podcast. Moderator Ken Herrmann, MD is joined by Simron Singh, MD and Lisa Bodei, MD, PhD to discuss NETTER-2, the first trial to examine radioligand therapy as a first-line therapy for cancers. Full episode here: https://t.co/atX4NW4XgG
The hard copies of "Radiopharmaceutical Therapy" have arrived! Managed to get a pic with my Co-Editors…. The book really is the perfect stocking filler @lisabodei@TheZeglisLab
It’s out!!! A huge thank you to all the contributors. Such a pleasure doing this with Professors @lisabodei and @TheZeglisLab. This book covers amazing the field of radiopharmaceutical therapy and is a real page turner. The perfect stocking filler 😀 https://t.co/QmZ4kYxH28
We will also have a tumor board focused on clinical applications of PSMA-targeted radioligand therapy. What an amazing panel including @morr316 @lisabodei@TubaKendi@CalaisJeremie. See what people think of cases like this. Looking forward to seeing everyone bright and early!
New Guideline Alert! Joint #SNMMI#EANM guideline for Lu-177 PSMA-targeted therapy will help practitioners select high-potential patients and prepare for clinical management. Thanks @EANM_NucMed!
https://t.co/X9md3fRHOy #NuclearMedicine#RPTherapy#ProstateCancer
Excited to announce the release of the @SNM_MI consensus statement on PSMA RLT. We attempted to wrangle with a number of difficult questions about how to use PSMA RLT in clinical practice. Check it out at: https://t.co/2vNmt3IYvd
1. For the first @SNMMI_CIC case, @lisabodei from @MSKCancerCenter presents a case of #PSMARLT where FDG PET, post-treatment SPECT and MRI all play a role in understanding response. Please watch the full video at https://t.co/5SA8iPVqi4.